IGFBP1 and Insulin resistance: The major finding of this study was that the circulating concentration of IGFBP-1 can identify the presence of insulin resistance in the group with BMI 1 to 2 SDS, even before the known markers of insulin resistance such as elevated TG and even before decreased HDL and adiponectin levels are identified.